Oncolytics Biotech Inc.
ONCY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $197,434 | $95,676 | $66,963 | $99,992 |
| - Cash | $12,352 | $14,626 | $15,303 | $15,942 |
| + Debt | $835 | $888 | $1,000 | $1,064 |
| Enterprise Value | $185,917 | $81,938 | $52,660 | $85,114 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$14,559 | -$5,612 | -$6,902 | -$8,339 |
| % Margin | – | – | – | – |
| Net Income | -$14,400 | -$6,165 | -$6,687 | -$8,017 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.14 | -0.068 | -0.079 | -0.1 |
| % Growth | -106.8% | 14.3% | 21% | – |
| Operating Cash Flow | -$6,651 | -$5,471 | -$6,498 | -$7,846 |
| Capital Expenditures | -$7 | $0 | $0 | -$6 |
| Free Cash Flow | -$6,658 | -$5,471 | -$6,498 | -$7,852 |